Semaglutide for Weight Loss

Semaglutide for Weight Loss

Semaglutide has recently been shown to induce clinically significant weight loss in patients with obesity that is sustained for as long as the drug is given. Tom Wadden, PhD, from the University of Pennsylvania, discusses results from the series of recent STEP trials and how they compare to the effects of other medications used to treat obesity.

Related Articles:

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Authors have declared conflicts of interest related to the article discussed in this podcast. Visit the article on jama.com for the complete disclosure.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(493)

Management of Dyslipidemia

Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author A...

20 Juli 0s

Hip Fractures: Management and Prevention

Hip Fractures: Management and Prevention

Hip fractures are a leading cause of disability and death in older adults. This episode summarizes  risk factors, prevention, and medical and surgical management of  hip fractures. JAMA Deputy Editor ...

16 Juli 19min

Alcohol-Related Liver Disease

Alcohol-Related Liver Disease

Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, o...

6 Juli 20min

An Overview of Familial Hypercholesterolemia

An Overview of Familial Hypercholesterolemia

Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Healt...

29 Juni 10min

Transforming Communication Between Patients and Clinicians

Transforming Communication Between Patients and Clinicians

Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant pro...

22 Juni 15min

Low Back Pain: Diagnosis and Treatment

Low Back Pain: Diagnosis and Treatment

Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews  risk factors, diagnosis, and current  evidence-based treatments for ac...

15 Juni 26min

Survivors of Cyanotic Congenital Heart Disease

Survivors of Cyanotic Congenital Heart Disease

Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD,...

8 Juni 23min

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of M...

3 Juni 16min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
hacka-livet
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
bildningspodden
det-morka-psyket
sexet
rss-vetenskapsradion
medicinvetarna
rss-vetenskapsradion-2
rss-kriminologerna
paranormalt-med-caroline-giertz
rss-spraket
4health-med-anna-sparre
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
rss-ronden
rss-odla